Publications
bioRxiv [Preprint]. April 2, 2025.
Mondal J, Lam D, Gerritsen ME, Brotz TM, Kennedy JG, Rehlaender B, Ross AJ, Levy DE, Bonagura CA, Lanzilotta WN, McCormick F, Rothman JH, Wolfe AL
IMPlications of IMP2 in RNA Biology and Disease
International Journal of Molecular Sciences. March 7, 2025.
Das J*, Busia-Bourdain O*, Khan KM, Wolfe AL
Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function
bioRxiv [Preprint]. July 16, 2024.
Lam D, Arroyo B, Liberchuk AN, Wolfe AL
Cadherin-17 as a target for the immunoPET of adenocarcinoma
European Journal of Nuclear Medicine and Molecular Imaging. April 16, 2024.
Delaney S, Keinänen O, Lam D, Wolfe AL, Hamakubo T, and Zeglis BM
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
Current Oncology. April 3, 2024.
Ash LA, Busia-Bourdain O, Okpattah D, Kamel A, Liberchuk A, and Wolfe AL
Targeting cancer’s sweet spot: UGP2 as a therapeutic vulnerability
Molecular and Cellular Oncology. October 27, 2021.
Proceedings of the National Academy of Sciences of the United States of America. August 3, 2021.
Wolfe AL, Zhou Q, Toska E, Galeas J, Ku AA, Koche RP, Bandyopadhyay S, Scaltriti M, Lebrilla CB, McCormick F*, Kim SE*
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer
Communications Biology. March 9, 2021.
Pappas K, Martin TC, Wolfe AL, Nguyen CB, Su T, Jin J, Hibshoosh H, Parsons R
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy
Cancers. February 5, 2021.
Sanghvi VR, Mohan P, Singh K, Cao L, Berishaj M, Wolfe AL, Schatz JH, Lailler N, de Stanchina E, Viale A, Wendel HG
Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity
Immunity. December 19, 2017.
Riquelme SA, Hopkins BD, Wolfe AL, DiMango E, Kitur K, Parsons R, Prince A
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia
Science Signaling. November 18, 2014.
Sanghvi VR, Mavrakis KJ, Van der Meulen J, Boice M, Wolfe AL, Carty M, Mohan P, Rondou P, Socci ND, Benoit Y, Taghon T, Van Vlierberghe P, Leslie CS, Speleman F, Wendel HG
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
Nature. September 4, 2014.
Wolfe AL*, Singh K*, Zhong Y, Drewe P, Rajasekhar VK, Sanghvi VR, Mavrakis KJ, Jiang M, Roderick JE, Van der Meulen J, Schatz JH, Rodrigo CM, Zhao C, Rondou P, de Stanchina E, Teruya-Feldstein J, Kelliher MA, Speleman F, Porco JA Jr, Pelletier J, Rätsch G, Wendel HG
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
Cell. October 28, 2011
Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, Jiang M, Liu X, Bruno J, Heguy A, Olshen AB, Socci ND, Teruya-Feldstein J, Weis-Garcia F, Tam W, Shaknovich R, Melnick A, Himanen JP, Chaganti RS, Wendel HG
Journal of Experimental Medicine. August 29, 2011.
Schatz JH, Oricchio E, Wolfe AL, Jiang M, Linkov I, Maragulia J, Shi W, Zhang Z, Rajasekhar VK, Pagano NC, Porco JA Jr, Teruya-Feldstein J, Rosen N, Zelenetz AD, Pelletier J, Wendel HG
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)
Nature Genetics. June 5, 2011.
Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, Khan AA, Setty M, Rondou P, Vandenberghe P, Delabesse E, Benoit Y, Socci NB, Leslie CS, Van Vlierberghe P, Speleman F, Wendel HG
Mouse models of cancer as biological filters for complex genomic data
Disease Models and Mechanisms. Nov-Dec 2010.
Oricchio E, Wolfe AL, Schatz JH, Mavrakis KJ, Wendel HG
Nature Cell Biology. February 28, 2010.
Mavrakis KJ*, Wolfe AL*, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, Parker JS, Paddison PJ, Tam W, Ferrando A, Wendel HG
*Denotes equal authorship contribution.